MedPath

Phase 2/3 Study of SK-0503 in Patients with Macular Edema Following Branch Retinal Vein Occlusio

Phase 2
Conditions
Macular edema following branch retinal vein occlusion
Registration Number
JPRN-jRCT2080221159
Lead Sponsor
SANWA KAGAKU KENKYUSHO Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients with macular edema that developed in the study eye from 52 weeks (364 days) to 6 weeks (42 days) prior to qualification/baseline visit
(2) Patients whose best corrected visual acuity is between 34 and 68 letters inclusive in the study eye as measured by the ETDRS method
(3) Patients with a central macular retinal thickness of at least 350 µm in the study eye as measured by optical coherence tomography

Exclusion Criteria

(1) Patients whose BCVA score of less than 34 letters measured by the ETDRS method at qualification/baseline visit
(2) Patients with a history of steroid-induced intraocular pressure elevation
(3) Patients with diabetic retinopathy
(4) Patients with cancer, serious liver disease, serious renal disease, or serious heart disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath